Milestone Pharmaceuticals Inc. Common Shares MIST

$0.76 -0.92% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K FORM 8-K 2026-09-03 View →
8-K FORM 8-K 2026-08-12 View →
10-Q 10-Q 2026-08-12 View →
8-K FORM 8-K 2026-06-15 View →
4 Insider transaction 2026-06-12 View →
4 Insider transaction 2026-06-12 View →
4 Insider transaction 2026-06-12 View →
4 Insider transaction 2026-06-12 View →
4 Insider transaction 2026-06-12 View →
4 Insider transaction 2026-06-12 View →
4 Insider transaction 2026-06-12 View →
S-3 S-3 2026-05-13 View →
8-K FORM 8-K 2026-05-13 View →
10-Q 10-Q 2026-05-13 View →
DEF 14A FORM DEF 14A 2026-04-30 View →
4 Insider transaction 2026-04-20 View →
8-K FORM 8-K 2026-03-20 View →
10-K 10-K 2026-03-20 View →
4 Insider transaction 2026-02-04 View →
4 Insider transaction 2026-02-04 View →
4 Insider transaction 2026-02-04 View →
4 Insider transaction 2026-02-04 View →
4 Insider transaction 2026-02-04 View →
4 Insider transaction 2026-01-28 View →
4 Insider transaction 2026-01-28 View →
4 Insider transaction 2026-01-28 View →
4 Insider transaction 2026-01-28 View →
4 Insider transaction 2026-01-28 View →
8-K FORM 8-K 2026-01-26 View →
8-K FORM 8-K 2026-01-13 View →
4 Insider transaction 2026-01-09 View →
8-K FORM 8-K 2026-01-06 View →
8-K FORM 8-K 2025-12-15 View →
4 Insider transaction 2025-12-11 View →
8-K FORM 8-K 2025-11-12 View →
10-Q 10-Q 2025-11-12 View →
8-K FORM 8-K 2025-08-12 View →
10-Q 10-Q 2025-08-12 View →
4 Insider transaction 2025-07-15 View →
4 Insider transaction 2025-07-15 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.76
Market Cap
$95.14 million
52-Week Range
$0.72 – $3.06
Average Volume
1.33 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.